Answers are grounded in this paper and cite their sources.
Pulmonary hypertension (PH) is associated with adverse outcomes in chronic kidney disease (CKD) patients. Our study suggests mildly elevated pulmonary vascular resistance ( > 2 to ≤ 3) is independently associated with major adverse cardiovascular events at 1‐year follow‐up. Early diagnosis of precapillary PH in CKD patients can potentially improve clinical outcomes.
No takes yet. Share an insight, caveat, or question.
Manzano et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: